Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$521M |
| 2 |
Nike
NKE
|
+$509M |
| 3 |
Micron Technology
MU
|
+$439M |
| 4 |
Super Micro Computer
SMCI
|
+$435M |
| 5 |
Broadcom
AVGO
|
+$329M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$5.31B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.89B |
| 3 |
Amazon
AMZN
|
+$1.48B |
| 4 |
Microsoft
MSFT
|
+$1.07B |
| 5 |
iShares Russell 2000 ETF
IWM
|
+$904M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 2.38% |
| 2 | Consumer Discretionary | 1.03% |
| 3 | Financials | 0.75% |
| 4 | Healthcare | 0.67% |
| 5 | Communication Services | 0.6% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MRNS
11151
PUT
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
| $74.6K | ﹤0.01% |
63,800
-287,000
| -82% | -$718K |
|
11152
PUT
Abeona Therapeutics
ABEO
$340M
| $74.6K | ﹤0.01% |
17,600
+4,100
| +30% | +$20.9K |
|
|
LUNA
11153
CALL
DELISTED
Luna Innovations Incorporated
LUNA
| $74.6K | ﹤0.01% |
23,300
-81,700
| -78% | -$242K |
|
|
ADAM
11154
Adamas Trust
ADAM
$877M
| $74.4K | ﹤0.01% |
+12,739
| New | +$81.7K |
|
11155
PUT
BARK
BARK
$94.6M
| $74.4K | ﹤0.01% |
2,055
-530
| -21% | -$13.6K |
|
11156
Outdoor Holding Co
POWW
$249M
| $74.2K | ﹤0.01% |
44,147
-246,212
| -85% | -$593K |
|
11157
CALL
Pyxis Oncology
PYXS
$274M
| $74.1K | ﹤0.01% |
22,400
-12,500
| -36% | -$52.6K |
|
11158
Quince Therapeutics
QNCX
$31.7M
| $74K | ﹤0.01% |
493
+9
| +2% | +$1.63K |
|
|
TEF
11159
DELISTED
Telefonica
TEF
| $73.9K | ﹤0.01% |
17,542
-59,454
| -77% | -$263K |
|
|
OGG
11160
PUT
Osisko Gold Group
OGG
$951M
| $73.7K | ﹤0.01% |
39,600
+19,500
| +97% | +$41.3K |
|
|
CKPT
11161
CALL
DELISTED
Checkpoint Therapeutics
CKPT
| $73.5K | ﹤0.01% |
34,200
-57,500
| -63% | -$102K |
|
11162
PUT
Oportun Financial
OPRT
$342M
| $73.4K | ﹤0.01% |
25,300
-13,900
| -35% | -$42.1K |
|
11163
CALL
KULR Technology Group
KULR
$125M
| $73.3K | ﹤0.01% |
22,913
+19,325
| +539% | +$69.3K |
|
|
NTZ
11164
Natuzzi
NTZ
| $73.1K | ﹤0.01% |
+14,919
| New | +$83K |
|
11165
PUT
Riskified
RSKD
$801M
| $72.8K | ﹤0.01% |
11,400
-100
| -0.9% | -$566 |
|
11166
Design Therapeutics
DSGN
$975M
| $72.8K | ﹤0.01% |
21,726
+10,494
| +93% | +$40.9K |
|
|
VTYX
11167
DELISTED
Ventyx Biosciences
VTYX
| $72.6K | ﹤0.01% |
31,435
-86,143
| -73% | -$358K |
|
|
AMRN
11168
Amarin Corp
AMRN
$304M
| $72.6K | ﹤0.01% |
+5,275
| New | +$90.7K |
|
11169
Xeris Biopharma Holdings
XERS
$1.58B
| $72.6K | ﹤0.01% |
32,246
+4,856
| +18% | +$9.79K |
|
|
ME
11170
CALL
DELISTED
23andMe Holding Co
ME
| $72.2K | ﹤0.01% |
9,250
+3,330
| +56% | +$31.9K |
|
|
ONTF
11171
CALL
DELISTED
ON24
ONTF
| $72.1K | ﹤0.01% |
+12,000
| New | +$76.2K |
|
11172
CALL
Kartoon Studios
TOON
$40.3M
| $72K | ﹤0.01% |
69,900
+4,800
| +7% | +$5.52K |
|
|
INZY
11173
CALL
DELISTED
Inozyme Pharma
INZY
| $71.8K | ﹤0.01% |
+16,100
| New | +$78.1K |
|
11174
PUT
Rekor Systems
REKR
$80.4M
| $71.8K | ﹤0.01% |
46,300
-26,700
| -37% | -$46.7K |
|
|
TWKS
11175
CALL
DELISTED
Thoughtworks Holding, Inc. Common Stock
TWKS
| $71.6K | ﹤0.01% |
25,200
-111,800
| -82% | -$300K |
|
Similar funds
Jeff Yass's Q2 2024 Portfolio in Review
As of Q2 2024, Jeff Yass held 13,638 positions worth $537B, down 6.7% from $576B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Jeff Yass's Q2 2024 filing shows 1,591 new, 4,593 increased, 5,607 reduced and 1,726 closed positions. Its largest new stake was NextEra Energy 7.299% Corporate Units: 2,575,000 shares worth $127M. The largest sale was NVIDIA, an estimated $5.31B.
By sector, the portfolio is most concentrated in Technology at 2.4% of assets, down from 3% a quarter earlier, followed by Consumer Discretionary and Financials.
- Jeff Yass's largest Q2 2024 buy was NextEra Energy 7.299% Corporate Units: 2,575,000 shares worth $127M.
- Jeff Yass added most to Vanguard FTSE Developed Markets ETF in Q2 2024, an estimated $521M increase.
- Jeff Yass's biggest Q2 2024 reduction was NVIDIA, cutting an estimated $5.31B.
- Jeff Yass fully exited iShares MSCI USA Quality Factor ETF in Q2 2024, selling an estimated $26.2M.
- Jeff Yass's ten largest holdings make up 26% of its $537B portfolio in Q2 2024.
- Jeff Yass opened 1,591 new positions and closed 1,726 in Q2 2024.
- Jeff Yass's portfolio value fell 6.7% quarter-over-quarter to $537B.
Based on Susquehanna International Group's 13F filing for Q2 2024, filed 15 Aug 2024.